The Hereditary Cancer Core provides Siteman Cancer Center members with expertise and support services to address and overcome barriers to cancer genetics research. Cancer genetics research is often difficult because of the general lack of participation from families with a history of cancer and fear of genetic research, inadequate clinical data for high-risk families, and difficulties in the recruitment of ethnically diverse populations. The Hereditary Cancer Core is organized to provide a broad range of services: . Project Management and Coordination of Study Participant Recruitment . Liaison with the Washington University School of Medicine (WUSM) Human Studies Committee . Design and Implementation of Cancer Genetics Research . Clinical Risk Assessment and Genetic Counseling . Medical Record Collection Service In addition, the core has recently launched a project referred to as the Cancer Free Controls Initiative, a St. Louis community based project to collect 2,000 blood samples with linked health and family history information from individuals 65 years of age and older who have no history of cancer. DNA and serum samples will be used in cancer case-control studies. The core is responsible for participant recruitment, specimen and data collection, and database management. Mark Watson, Director of the Tissue Procurement Core, processes the samples for genetic and protein studies. Samples will be made available to SCC investigators with approved cancer research protocols.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA091842-04
Application #
6998198
Study Section
Subcommittee G - Education (NCI)
Project Start
2004-09-21
Project End
2009-06-30
Budget Start
2004-09-21
Budget End
2005-06-30
Support Year
4
Fiscal Year
2004
Total Cost
$62,258
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Salloum, Naji C; Buchalter, Erica Lf; Chanani, Swati et al. (2018) From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation. Pharmacogenomics 19:861-871
Aliev, Fazil; Salvatore, Jessica E; Agrawal, Arpana et al. (2018) A Brief Critique of the TATES Procedure. Behav Genet 48:155-167
Mills, Jason C; Samuelson, Linda C (2018) Past Questions and Current Understanding About Gastric Cancer. Gastroenterology 155:939-944
Shepherd, Andrew J; Copits, Bryan A; Mickle, Aaron D et al. (2018) Angiotensin II Triggers Peripheral Macrophage-to-Sensory Neuron Redox Crosstalk to Elicit Pain. J Neurosci 38:7032-7057
Dehdashti, Farrokh; Wu, Ningying; Bose, Ron et al. (2018) Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer. Breast Cancer Res Treat 169:523-530
Donabedian, Patrick L; Kossatz, Susanne; Engelbach, John A et al. (2018) Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models. EJNMMI Res 8:59
Groves, Andrew P; Gettinger, Katie; Druley, Todd E et al. (2018) Special Therapy and Psychosocial Needs Identified in a Multidisciplinary Cancer Predisposition Syndrome Clinic. J Pediatr Hematol Oncol :
Andley, Usha P; Tycksen, Eric; McGlasson-Naumann, Brittney N et al. (2018) Probing the changes in gene expression due to ?-crystallin mutations in mouse models of hereditary human cataract. PLoS One 13:e0190817
Sáenz, José B; Mills, Jason C (2018) Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer. Nat Rev Gastroenterol Hepatol 15:257-273
Miller, Christopher A; Tricarico, Christopher; Skidmore, Zachary L et al. (2018) A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel RARG-CPSF6 fusion. Blood Adv 2:1295-1299

Showing the most recent 10 out of 1244 publications